45 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product under
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
with all statutes, rules and regulations applicable to the testing, development, manufacture, packaging, processing, use, distribution, marketing
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
revenue, our business and our results of operations.
The research, development, testing, manufacturing, labeling, packaging, approval, promotion … on third parties, such as CROs, investigational product packaging, labeling and distribution, laboratories, medical institutions and clinical
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
to generate revenue, our business and our results of operations.
The research, development, testing, manufacturing, labeling, packaging, approval … .
We rely on third parties, such as CROs, investigational product packaging, labeling and distribution, laboratories, medical institutions
8-K
EX-1.1
qaxa07c1sw4x
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
ai9aaqe1or2t
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
wvlhjw
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
dkipu04p
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-1.1
mafz92bn cfe2ejsd
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
q1ozgko
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
egqmbzjrevgca4 xf3d
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
1xpkar3956ua xxkr5m1
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
gos h53k6
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
7jgsi 6dq2e9b30k
12 Apr 19
Prospectus supplement
4:41pm